Transgene S.A. buy metanicnor
Start price
31.05.14
/
50%
€9.91
Target price
18.05.15
€14.00
Performance (%)
-50.20%
End price
18.05.15
€4.94
Summary
This prediction ended on 18.05.15 with a price of €4.94. The BUY prediction by metanicnor for Transgene S.A. performed very badly with a performance of -50.20%. metanicnor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Transgene S.A. | -7.125% | -7.125% | 12.500% | -60.829% |
| iShares Core DAX® | -1,34 % | -5,62 % | 3,38 % | 51,20 % |
| iShares Nasdaq 100 | -1,07 % | 2,60 % | 19,13 % | 93,73 % |
| iShares Nikkei 225® | -1,99 % | -6,51 % | 27,85 % | 51,19 % |
| iShares S&P 500 | -1,32 % | 0,91 % | 14,19 % | 65,29 % |
Comments by metanicnor for this prediction
In the thread Transgene S.A. diskutieren
TG4010
Vielversprechende Ergebnisse einer Studie über TG4010
bald in Phase-III-sein?
Transgen suche einen Finanzpartner
Termin im September 2014 detaillierte Ergebnisse auf TG4010
(Laufzeit überschritten)